Livforsakringsbolaget Skandia Omsesidigt Invests $3.77 Million in Tenet Healthcare Corporation $THC

Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 18,600 shares of the company’s stock, valued at approximately $3,773,000.

Several other institutional investors have also added to or reduced their stakes in the company. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the third quarter valued at approximately $25,000. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare during the 2nd quarter valued at $35,000. Westside Investment Management Inc. grew its position in Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the last quarter. Finally, Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare during the third quarter worth $41,000. Institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 8,000 shares of Tenet Healthcare stock in a transaction on Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the transaction, the executive vice president directly owned 12 shares in the company, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 46,517 shares of company stock valued at $10,943,111. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Down 3.4%

Shares of Tenet Healthcare stock opened at $211.88 on Wednesday. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market cap of $18.43 billion, a price-to-earnings ratio of 13.68, a PEG ratio of 1.06 and a beta of 1.39. The firm’s 50-day moving average is $213.78 and its two-hundred day moving average is $204.75.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Truist Financial upped their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. UBS Group raised their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Morgan Stanley reaffirmed an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 12th. Finally, Jefferies Financial Group increased their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $250.56.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.